Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01192542 · ClinicalTrials.gov registry record · NA
Pilot Evaluation of a New Galyfilcon A Lens Prototype and Enfilcon A Lens
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT01192542 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 39 participants.
The verdict
NCT01192542, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the visual acuity, limbal and bulbar redness of the new galyfilcon A prototype lenses against Avaira® lenses when worn as daily wear for seven (7) days.
Interventions
- DEVICE galyfilcon A prototype lens
- DEVICE enfilcon A lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2010-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01192542
The ClinicalTrials.gov registry entry for NCT01192542 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which galyfilcon A prototype lens is the first listed.
NCT01192542 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01192542 about?
NCT01192542 is a clinical study titled "Pilot Evaluation of a New Galyfilcon A Lens Prototype and Enfilcon A Lens". The purpose of this study is to compare the visual acuity, limbal and bulbar redness of the new galyfilcon A prototype lenses against Avaira® lenses when worn as daily wear for seven (7) days.
What is the current status of trial NCT01192542?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2010-08.
What interventions are being tested in trial NCT01192542?
The interventions under investigation include: galyfilcon A prototype lens (DEVICE), enfilcon A lens (DEVICE).
Who is sponsoring clinical trial NCT01192542?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.